PRESS RELEASE TreeFrog Therapeutics raises over €7M ($7.8M) in Series A financing round 6 months after incorporation   Funding to scale-up company’s proprietary technology C-Stem™ for mass-production of safe and affordable cell therapies   Bordeaux, France, May 13, 2019 – TreeFrog Therapeutics, an expert stem cell company, today announces that...

  C- Stem™ technology introduces a new standard for hIPS suspension culture. Based on biomimetic stem cell culture in 3D, C- Stem™ enables cell therapy production scale-up while ensuring genomic and phenotypic stability   Bordeaux, France, April 16, 2019 – TreeFrog Therapeutics, an expert stem cell company, today...